Literature DB >> 30850053

Approaches for investigating the extracellular signaling function of ISG15.

Caleb D Swaim1, Larissa A Canadeo1, Jon M Huibregtse2.   

Abstract

ISG15 is a ubiquitin-like protein (Ubl) that is expressed in response to Type 1 Interferon (IFN-α/β) signaling. Remarkably, ISG15 has three distinct biochemical activities involved in innate immune responses to viral and/or microbial infections. The canonical function of ISG15 is as a posttranslational modifier, and protein ISGylation has been demonstrated to be antiviral. A second intracellular function, independent of conjugation activity, is attenuation of IFN-α/β signaling at the interferon receptor, which appears to be important for terminating IFN responses. The third function of ISG15, and the focus of this chapter, is as an extracellular signaling molecule that promotes the secretion of Type 2 Interferon (IFN-γ) by Natural Killer (NK) cells. This function is important for control of microbial infections, including mycobacterial infections. Here, we describe methods for purification of ISG15, preparation, and culture of primary peripheral blood mononuclear cells (PBMCs) and NK-92 cells, assays for IL-12- and ISG15-dependent cytokine (IFN-γ and IL-10) secretion, and assays for initial intracellular signaling events triggered by extracellular ISG15.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine secretion; ISG15; Interferon gamma; LFA-1 integrin signaling; Natural killer cells; Ubiquitin-like protein

Mesh:

Substances:

Year:  2019        PMID: 30850053      PMCID: PMC6472260          DOI: 10.1016/bs.mie.2018.12.027

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  38 in total

1.  Crystal structure of the interferon-induced ubiquitin-like protein ISG15.

Authors:  Jana Narasimhan; Ming Wang; Zhuji Fu; Jennifer M Klein; Arthur L Haas; Jung-Ja P Kim
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

2.  Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein.

Authors:  W Yuan; R M Krug
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

3.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

Authors:  Chen Zhao; Carilee Denison; Jon M Huibregtse; Steven Gygi; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

4.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.

Authors:  Oxana A Malakhova; Keun Il Kim; Jiann-Kae Luo; Weiguo Zou; K G Suresh Kumar; Serge Y Fuchs; Ke Shuai; Dong-Er Zhang
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

5.  The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.

Authors:  Sara Tokarz; Catherine Berset; Janna La Rue; Kevin Friedman; Kei-Ichi Nakayama; Keiko Nakayama; Dong-Er Zhang; Stefan Lanker
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

6.  Immunoregulatory properties of ISG15, an interferon-induced cytokine.

Authors:  J D'Cunha; E Knight; A L Haas; R L Truitt; E C Borden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners.

Authors:  Hazel F O'Connor; Nancy Lyon; Justin W Leung; Poonam Agarwal; Caleb D Swaim; Kyle M Miller; Jon M Huibregtse
Journal:  EMBO Rep       Date:  2015-10-27       Impact factor: 8.807

8.  HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells.

Authors:  Diede Oudshoorn; Sander van Boheemen; Maria Teresa Sánchez-Aparicio; Ricardo Rajsbaum; Adolfo García-Sastre; Gijs A Versteeg
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies.

Authors:  Kirby N Swatek; Martina Aumayr; Jonathan N Pruneda; Linda J Visser; Stephen Berryman; Anja F Kueck; Paul P Geurink; Huib Ovaa; Frank J M van Kuppeveld; Tobias J Tuthill; Tim Skern; David Komander
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 10.  Type I interferonopathies in pediatric rheumatology.

Authors:  Stefano Volpi; Paolo Picco; Roberta Caorsi; Fabio Candotti; Marco Gattorno
Journal:  Pediatr Rheumatol Online J       Date:  2016-06-04       Impact factor: 3.054

View more
  1 in total

Review 1.  Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).

Authors:  Inbar Magid Gold; Noa Reis; Fabian Glaser; Michael H Glickman
Journal:  Semin Cell Dev Biol       Date:  2022-06-25       Impact factor: 7.499

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.